Debjani Dutta

804 citations
11 papers · 598 indexed · h-index 6
Topics
Signaling Pathways in Disease (5 papers)Peptidase Inhibition and Analysis (3 papers)T-cell and B-cell Immunology (3 papers)

In The Last Decade

Debjani Dutta

11 papers receiving 581 citations

Peers

Debjani Dutta
Comparison fields: 5 of 70
  • Molecular Biology 379
  • Cancer Research 210
  • Oncology 162
  • Immunology 73
  • Genetics 67
Replace Kaiyan Yang with:
Kaiyan Yang China
Xiaoyan Lou China
Kyeong‐Man Hong South Korea
Masahiko Ajiro Japan
Subing Cao United States
Daifeng Jiang United States
Jingmin Zhao China
Motoki Takaku United States
Svenja Debey‐Pascher Germany
Pierre Martinez France
Debjani Dutta relative to Kaiyan Yang China Kaiyan Yang's profile →
Citations per field
00.5×1.5×
Kaiyan Yang · 1×
Citations per year

Countries citing papers authored by Debjani Dutta

Since Specialization
Citations

This map shows the geographic impact of Debjani Dutta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debjani Dutta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debjani Dutta more than expected).

Fields of papers citing papers by Debjani Dutta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debjani Dutta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debjani Dutta. The network helps show where Debjani Dutta may publish in the future.

Co-authorship network of co-authors of Debjani Dutta

This figure shows the co-authorship network connecting the top 25 collaborators of Debjani Dutta. A scholar is included among the top collaborators of Debjani Dutta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debjani Dutta. Debjani Dutta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 2
2 5
3 24
4 1
5 21
6 1
7 67
8 25
9 22
10
Optimized RNA extraction and RT-PCR assays provide successful molecular analysis on a wide variety of archival fixed tissues
4
11 426

About Debjani Dutta

Debjani Dutta is a scholar working on Immunology and Allergy, Oncology and Molecular Biology, having authored 11 papers that have together received 598 indexed citations. Recurring topics across this work include Signaling Pathways in Disease (5 papers), Peptidase Inhibition and Analysis (3 papers) and T-cell and B-cell Immunology (3 papers). The work is most often cited by research in Cancer Research (210 citations), Oncology (162 citations) and Molecular Biology (379 citations). Debjani Dutta has collaborated with scholars based in United States, India and Germany. Frequent co-authors include Maureen Cronin, Steven Shak, Michael Kiefer, Joffre Baker, Mylan Pho, James C. Stephans, José Miguel Esteban López-Jamar, Jonathan D. Ashwell, Itoro Akpan and Valarie A. Barr. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026